Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 12:37 pm Purchase | 2022-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | CHI Advisors LLC | 3,199,892 6.560% | 630,413 (+24.53%) | Filing History |
| 2023-02-13 12:36 pm Purchase | 2022-12-31 | 13G | Oncorus, Inc. ONCR | CHI Advisors LLC | 2,367,436 9.110% | 260,533 (+12.37%) | Filing History |
| 2023-02-13 12:36 pm Purchase | 2022-12-31 | 13G | Cullinan Oncology, Inc. CGEM | CHI Advisors LLC | 3,317,544 7.250% | 840,824 (+33.95%) | Filing History |
| 2023-02-13 12:09 pm Purchase | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | CHI Advisors LLC | 2,204,876 5.460% | 2,204,876 (New Position) | Filing History |
| 2023-02-13 12:08 pm Purchase | 2022-12-31 | 13G | VectivBio Holding AG VECT | CHI Advisors LLC | 5,492,893 8.760% | 2,817,485 (+105.31%) | Filing History |
| 2023-02-13 12:07 pm Purchase | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | CHI Advisors LLC | 2,800,126 6.670% | 587,870 (+26.57%) | Filing History |
| 2023-02-13 12:06 pm Purchase | 2022-12-31 | 13G | Orchard Therapeutics plc ORTX | CHI Advisors LLC | 798,740 6.300% | 153,754 (+23.84%) | Filing History |
| 2023-02-13 12:04 pm Purchase | 2022-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | CHI Advisors LLC | 3,473,366 8.030% | 1,958,218 (+129.24%) | Filing History |
| 2023-02-13 12:01 pm Purchase | 2022-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN | CHI Advisors LLC | 320,961 7.410% | 195,869 (+156.58%) | Filing History |
| 2023-02-13 12:01 pm Purchase | 2022-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | CHI Advisors LLC | 2,384,402 5.120% | 2,384,402 (New Position) | Filing History |
| 2022-02-11 1:51 pm Purchase | 2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | CHI Advisors LLC | 2,569,479 7.130% | 214,680 (+9.12%) | Filing History |
| 2022-02-11 1:51 pm Purchase | 2021-12-31 | 13G | Oncorus, Inc. ONCR | CHI Advisors LLC | 2,106,903 8.160% | 426,997 (+25.42%) | Filing History |
| 2022-02-11 1:39 pm Purchase | 2021-12-31 | 13G | Cullinan Oncology, Inc. CGEM | CHI Advisors LLC | 2,476,720 5.670% | 2,476,720 (New Position) | Filing History |
| 2022-02-11 1:01 pm Purchase | 2021-12-31 | 13G | Orchard Therapeutics plc ORTX | CHI Advisors LLC | 644,986 5.140% | 644,986 (New Position) | Filing History |
| 2022-02-11 1:00 pm Purchase | 2021-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN | CHI Advisors LLC | 125,093 5.240% | 125,093 (New Position) | Filing History |
| 2022-02-11 12:59 pm Purchase | 2021-12-31 | 13G | VectivBio Holding AG VECT | CHI Advisors LLC | 2,675,408 7.610% | 2,675,408 (New Position) | Filing History |
| 2022-02-11 11:36 am Sale | 2021-12-31 | 13G | Repare Therapeutics Inc. RPTX | CHI Advisors LLC | 2,212,256 5.300% | -319,894 (-12.63%) | Filing History |
| 2022-02-11 11:34 am Unchanged | 2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | CHI Advisors LLC | 1,515,148 8.560% | 0 (Unchanged) | Filing History |
| 2021-03-02 3:41 pm Purchase | 2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | CHI Advisors LLC | 2,354,799 6.600% | 2,354,799 (New Position) | Filing History |
| 2021-03-02 3:37 pm Purchase | 2020-12-31 | 13G | Oncorus, Inc. ONCR | CHI Advisors LLC | 1,679,906 6.600% | 1,679,906 (New Position) | Filing History |